The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells

被引:36
作者
Burek, C
Roth, J
Koch, HG
Harzer, K
Los, M
Schulze-Osthoff, K
机构
[1] Univ Munich, Dept Immunol & Cell Biol, D-48149 Munster, Germany
[2] Univ Munster, Dept Pediat, D-4400 Munster, Germany
[3] Univ Tubingen, Neurochem Lab, Tubingen, Germany
关键词
apoptosis; ceramide; ceramidase; CD95; Farber disease;
D O I
10.1038/sj.onc.1204841
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activation of sphingomyelinases leading to the generation of ceramide has been implicated in various apoptotic pathways. However, the role of ceramide as an essential death mediator remains highly controversial. In the present study, we investigated the functional relevance of ceramide in a genetic model by using primary cells from a Farber disease patient. These cells accumulate ceramide as the result of an inherited deficiency of acidic ceramidase. We demonstrate that Farber disease lymphocytes and fibroblasts underwent apoptosis induced by various stress stimuli, including staurosporine, anticancer drugs and gamma -irradiation, equally as normal control cells. In addition, caspase activation by these proapoptotic agents occurred rather similarly in Farber disease and control fibroblasts. Interestingly, Farber disease lymphoid cells underwent apoptosis induced by the CD95 death receptor more rapidly than control cells. Our data therefore suggest that ceramide does not play an essential role as a second messenger in stress-induced apoptosis. However, in accordance with a role in lipid-rich microdomains, ceramide by altering membrane composition may function as an amplifier in CD95-mediated apoptosis.
引用
收藏
页码:6493 / 6502
页数:10
相关论文
共 49 条
  • [1] Bezombes C, 2001, FASEB J, V15, P297
  • [2] CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase
    Boesen-de Cock, JGR
    Tepper, AD
    de Vries, E
    van Blitterswijk, WJ
    Borst, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (13) : 7560 - 7565
  • [3] CERAMIDE SYNTHASE MEDIATES DAUNORUBICIN-INDUCED APOPTOSIS - AN ALTERNATIVE MECHANISM FOR GENERATING DEATH SIGNALS
    BOSE, R
    VERHEIJ, M
    HAIMOVITZFRIEDMAN, A
    SCOTTO, K
    FUKS, Z
    KOLESNICK, R
    [J]. CELL, 1995, 82 (03) : 405 - 414
  • [4] Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue
    Chatelut, M
    Leruth, M
    Harzer, K
    Dagan, A
    Marchesini, S
    Gatt, S
    Salvayre, R
    Courtoy, P
    Levade, T
    [J]. FEBS LETTERS, 1998, 426 (01) : 102 - 106
  • [5] A simple method for screening for Farber disease on cultured skin fibroblasts
    Chatelut, M
    Feunteun, J
    Harzer, K
    Fensom, AH
    Basile, JP
    Salvayre, R
    Levade, T
    [J]. CLINICA CHIMICA ACTA, 1996, 245 (01) : 61 - 71
  • [6] APOPTOTIC SIGNALING THROUGH CD95 (FAS/APO-1) ACTIVATES AN ACIDIC SPHINGOMYELINASE
    CIFONE, MG
    DEMARIA, R
    RONCAIOLI, P
    RIPPO, MR
    AZUMA, M
    LANIER, LL
    SANTONI, A
    TESTI, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1547 - 1552
  • [7] Ceramide enables Fas to cap and kill
    Cremesti, A
    Paris, F
    Grassmé, H
    Holler, N
    Tschopp, J
    Fuks, Z
    Gulbins, E
    Kolesnick, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) : 23954 - 23961
  • [8] Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells
    De Maria, R
    Rippo, MR
    Schuchman, EH
    Testi, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) : 897 - 902
  • [9] Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis
    DeMaria, R
    Lenti, L
    Malisan, F
    dAgostino, F
    Tomassini, B
    Zeuner, A
    Rippo, MR
    Testi, R
    [J]. SCIENCE, 1997, 277 (5332) : 1652 - 1655
  • [10] Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis
    Engels, IH
    Stepczynska, A
    Stroh, C
    Lauber, K
    Berg, C
    Schwenzer, R
    Wajant, H
    Jänicke, RUU
    Porter, AG
    Belka, C
    Gregor, M
    Schulze-Osthoff, K
    Wesselborg, S
    [J]. ONCOGENE, 2000, 19 (40) : 4563 - 4573